Paper list

書類用論文リスト

論文

Ryuichi Kumata, Shoya Iwanami, Katrina B. Mar, Yusuke Kakizoe, Naoko Misawa, Shinji Nakaoka, Yoshio Koyanagi, Alan S. Perelson, John W. Schoggins, Shingo Iwami*, Kei Sato*. Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection. PLOS Computational Biology (2022) 18(4): e1010053. DOI: 10.1371/journal.pcbi.1010053
Makoto Yoshida, Yurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, Yoshitaka Nishikawa, Fumiya Omata, Tianchen Zhao, Chika Yamamoto, Yudai Kaneko, Aya Nakayama, Morihito Takita, Naomi Ito, Moe Kawashima, Sota Sugiura, Kenji Shibuya, Shingo Iwami, Kwangsu Kim, Shoya Iwanami, Tatsuhiko Kodama, Masaharu Tsubokura. Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey. Vaccines (2022) 10(4):515. DOI: 10.3390/vaccines10040515
Marwa Akao, Joohyeon Woo, Shingo Iwami, Shoya Iwanami*. Detection of significant antiviral drug effects on COVID-19 using viral load and PCR-positive rate in randomized controlled trials. Translational and Regulatory Sciences (2021) Volume 3 Issue 3 Pages 85-88. DOI: 10.33611/trs.2021-025
Kwang Su Kim, Shoya Iwanami, Takafumi Oda, Yasuhisa Fujita, Keiji Kuba, Taiga Miyazaki, Keisuke Ejima‡*, Shingo Iwami‡*. Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection. Life Science Alliance (2021) 4 (10) e202101049. DOI: 10.26508/lsa.202101049
Yong Dam Jeong, Keisuke Ejima†*, Kwang Su Kim, Shoya Iwanami, Ana I Bento, Yasuhisa Fujita, Il Hyo Jung, Kazuyuki Aihara, Koichi Watashi, Taiga Miyazaki, Takaji Wakita, Shingo Iwami*, Marco Ajelli. Revisiting the guidelines for ending isolation for COVID-19 patients. eLife (2021) 10:e69340. DOI: 10.7554/eLife.69340
Shoya Iwanami, Keisuke Ejima†*, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, Shigeru Kohno, Yoshitsugu Miyazaki, Shimpei Morimoto, Shinji Nakaoka, Yoshiki Koizumi, Yusuke Asai, Kazuyuki Aihara, Koichi Watashi, Robin N. Thompson, Kenji Shibuya, Katsuhito Fujiu, Alan S. Perelson, Shingo Iwami‡*, Takaji Wakita. Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study. PLOS Medicine (2021) 18(7):e1003660. DOI: doi.org/10.1371/journal.pmed.1003660
Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Shingo Iwami, Yoshimasa Takahashi, Tadaki Suzuki, Masamichi Muramatsu, Makoto Takeda, Takaji Wakita and Koichi Watashi. Mefloquine, a potent anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) drug as an entry inhibitor in vitro. Frontiers in Microbiology (2021) 12:651403. DOI: 10.3389/fmicb.2021.651403
Keisuke Ejima, Kwang Su Kim, Shoya Iwanami, Yasuhisa Fujita, Ming Li, Roger S. Zoh, Kazuyuki Aihara, Taiga Miyazaki, Takaji Wakita and Shingo Iwami (These authors contributed equally to this work.). Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model. Journal of the Royal Society Interface (2021) 18: 20200947. 20200947.. DOI: 10.1098/rsif.2020.0947
Keisuke Ejima, Kwang Su Kim, Christina Ludema, Ana I. Bento, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Koichi Watashi, Kazuyuki Aihara, Hiroshi Nishiura and Shingo Iwami. Estimation of the incubation period of COVID-19 using viral load data. Epidemics (2021) 100454. DOI: 10.1016/j.epidem.2021.100454
Hirofumi Ohashi, Koichi Watashi, Wakana Saso, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim, Takao Nomura, Tateki Suzuki, Kazane Nishioka, Shuji Ando, Keisuke Ejima, Yoshiki Koizumi, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Tadaki Suzuki, Takao Hashiguchi, Katsumi Maenaka, Tetsuro Matano, Masamichi Muramatsu, Masayuki Saijo, Kazuyuki Aihara, Shingo Iwami, Makoto Takeda, Jane A. McKeating and Takaji Wakita. Potential anti-COVID-19 agents, Cepharanthine and Nelfinavir, and their usage for combination treatment. iScience (2021) 102367. DOI: 10.1016/j.isci.2021.102367
Kwang Su Kim, Keisuke Ejima, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Kazuyuki Aihara, Robin N. Thompson, Ruian Ke, Alan S. Perelson and Shingo Iwami. A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2. PLOS Biology (2021) 19(3): e3001128. DOI: 10.1371/journal.pbio.3001128
Shoya Iwanami, Kosaku Kitagawa, Hirofumi Ohashi, Yusuke Asai, Kaho Shionoya, Wakana Saso, Kazane Nishioka, Hisashi Inaba, Shinji Nakaoka, Takaji Wakita, Odo Diekmann, Shingo Iwami and Koichi Watashi. Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma. PLOS Biology (2020) 18(7): e3000562. DOI: 10.1371/journal.pbio.3000562
Hara A., Iwanami S., Ito Y., Miura T., Nakaoka S., and Iwami S.. Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque. Journal of Theoretical Biology (2019) 479:29-36. DOI: 10.1016/j.jtbi.2019.07.005
Iwanami S., Kakizoe Y., Morita S., Miura T., Nakaoka S., and Iwami S.. A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture. Theoretical Biology and Medical Modeling (2017) 14:9. DOI: 10.1186/s12976-017-0055-8

プレプリント

Naotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, Yuta Tani, Yuzo Shimazu, Tianchen Zhao, Yoshitaka Nishikawa, Fumiya Omata, Moe Kawashima, Makoto Yoshida, Toshiki Abe, Yoshika Saito, Yuki Senoo, Saori Nonaka, Morihito Takita, Chika Yamamoto, Takeshi Kawamura, Akira Sugiyama, Aya Nakayama, Yudai Kaneko, Hyeongki Park, Yong Dam Jeong, Daiki Tatematsu, Marwa Akao, Yoshitaka Sato, Shoya Iwanami, Yasuhisa Fujita, Masatoshi Wakui, Kazuyuki Aihara, Tatsuhiko Kodama, Kenji Shibuya, Shingo Iwami, Masaharu Tsubokura. Stratifying elicited antibody dynamics after two doses of SARS-CoV-2 vaccine in a community-based cohort in Fukushima, Japan. medRxiv. (2022) DOI: https://doi.org/10.1101/2022.06.11.22276266
Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, Kwang Su Kim, Joohyeon Woo, Kaho Shionoya, Kana Tsuchimoto, Shoya Iwanami, Saya Moriyama, Hitomi Kinoshita, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Hideki Ebihara, Tadaki Suzuki, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Shingo Iwami, Koichi Watashi. Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2. bioRxiv. (2022) DOI: https://doi.org/10.1101/2022.02.27.482147
Shiho Torii, Kwang Su Kim, Jun Koseki, Rigel Suzuki, Shoya Iwanami, Yasuhisa Fujita, Yong Dam Jeong, Yoshiharu Matsuura, Teppei Shimamura, Shingo Iwami, Takasuke Fukuhara. Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulation. bioRxiv. (2022) DOI: https://doi.org/10.1101/2022.02.22.481436
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, Il Hyo Jung, Kenji Shibuya, Shingo Iwami, Ana I. Bento, Marco Ajelli. Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models. medRxiv. (2022) DOI: https://doi.org/10.1101/2022.01.24.22269769
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Shoya Iwanami, Shingo Iwami, Kazuyuki Aihara. Safely return to schools and offices: early and frequent screening with high sensitivity antigen tests effectively identifies COVID-19 patients. medRxiv. (2021) DOI: https://doi.org/10.1101/2021.10.08.21264782
Keisuke Ejima, Kwang Su Kim, Yusuke Ito, Shoya Iwanami, Hirofumi Ohashi, Yoshiki Koizumi, Koichi Watashi, Ana I. Bento, Kazuyuki Aihara, Shingo Iwami. Inferring Timing of Infection Using Within-host SARS-CoV-2 Infection Dynamics Model: Are “Imported Cases” Truly Imported?. medRxiv. (2020) DOI: https://doi.org/10.1101/2020.03.30.20040519


Update: Jun 22, 2022